alexa Abstract | Incidence and Antibiotic Susceptibility Pattern of Pseudomonas aeruginosa Isolated from Inpatients in Two Tertiary Hospitals
ISSN: 2327-5073

Clinical Microbiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


Pseudomonas aeruginosa (P. aeruginosa) has been reported as the most commonly isolated organisms in hospitals. The increasing resistance rate of P. aeruginosa to the common antimicrobial drugs has been reported worldwide. The present study aimed to investigate the incidence and antibiotic susceptibility pattern of P. aeruginosa from inpatients of two hospitals. Out of 1235 patient specimens, a total of 108 (8.7%) non-duplicated P. aeruginosa clinical isolates were identified, majority of them were from males (59.3%) and from patients above 60 years (31.5%). The most common incidence rate was from male ward (43.5%) followed by female ward (20.4%). Majority of P. aeruginosa strains were isolated from sputum specimen (38%) followed by urine specimen (14.8%). The results showed that 42.6% of the isolates were sensitive to all antibiotics while 36.1 % were found to be resistant to more than three antibiotics. The study showed that maximum antibiotic susceptibility rate of P. aeruginosa isolates was against amikacin (83.3%) followed by ciprofloxacin (75.9%). The maximum resistance rates among P. aeruginosa isolates were against Piperacillin/Tazobactum (38.5 %,) followed by cefepime (32.4%). It was concluded that among P. aeruginosa isolates, amikacin was the most susceptible antimicrobial drug while piperacillin-tazobactam and cefipime were most resistant ones. Interventions and strategies to stop high resistance rate and optimizing therapy are needed.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Omar Bashir Ahmed


P. aeruginosa, Amikacin, Piperacillin-tazobactam, Antibiotics, Resistance, P. aeruginosa, Amikacin, Piperacillin-tazobactam, Antibiotics, Resistance

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version